FDA Approves Cytokinetics’ Myqorzo for Obstructive Hypertrophic Cardiomyopathy

January 3, 2026

MorphoSys hands over preclinical cancer program to Novartis for a $23M payout

December 13, 2022

Voranigo Receives FDA Clearance as a Brain Tumor Inhibitor

August 8, 2024

Must Read

Partner Therapeutics’ Bizengri Grabs FDA Green Light

May 14, 2026

Daiichi Revises ADC Supply Plans After Changes in Cancer Drug Demand Forecasts

May 14, 2026

Lilly Studies Show Weight Loss Maintenance After Switching to Foundayo or Lower-Dose Zepbound

May 14, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research

Merck Gets $700M Funding From Blackstone For Cancer Therapy R&D

Lilly Studies Show Weight Loss Maintenance After Switching to Foundayo or Lower-Dose Zepbound

Inhibrx Reports Higher Response Rate for INBRX-106 and Keytruda in Midphase Head and Neck Cancer Trial

CellCentric Raises $220 Million Series D to Advance Inobrodib and Launch Phase 3 Myeloma Trial

Entrada Therapeutics Reports 2.36% Dystrophin Increase in Early DMD Trial Data

Bayer Expands Opthalmology Pipeline With $2.4B Perfuse Acquisition

Madrigal Licenses ARO-PNPLA3 from Arrowhead in Deal Worth Up to $1 Billion

Amgen Adds $300 Million to Puerto Rico Expansion, Bringing U.S. Investment Commitments Near $2 Billion

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

5 Life Sciences Trends Defining the Next Decade of Healthcare Innovation

Can AI Reduce Drug Development Costs Without Increasing Risk?

Top 10 Skills Every Life Sciences Professional Needs in 2026

How Are Life Sciences Companies Reducing Environmental Impact Across Supply Chains?

Clinical

The Keytruda regimen study by Merck fails to reach its primary goal

Editor Picks

FDA Approves Cytokinetics’ Myqorzo for Obstructive Hypertrophic Cardiomyopathy

MorphoSys hands over preclinical cancer program to Novartis for a $23M payout

Voranigo Receives FDA Clearance as a Brain Tumor Inhibitor

Must Read

Partner Therapeutics’ Bizengri Grabs FDA Green Light

Daiichi Revises ADC Supply Plans After Changes in Cancer Drug Demand Forecasts

Lilly Studies Show Weight Loss Maintenance After Switching to Foundayo or Lower-Dose Zepbound

Hot Topics

About Us

Follow Us